Vimarsana
Biggest News Aggregation in the World

Peterp Toth News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Peterp Toth. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Peterp Toth Today - Breaking & Trending Today

Latest Research Evaluating Clinical Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the European Society of Cardiology (ESC) Congress - Vimarsana News

Latest Research Evaluating Clinical Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the European Society of Cardiology (ESC) Congress

DUBLIN, Ireland and BRIDGEWATER, N.J., July 26, 2023 -- Amarin Corporation plc today announced the acceptance of funded research for presentation at the European Society of Cardiology Congress,...

Resverlogix Publishes New Data Highlighting Apabetalone's - Vimarsana News

Resverlogix Publishes New Data Highlighting Apabetalone's

CALGARY, Alberta, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX) today announced the publication of an article entitled...

About 1 in 4 Adults has an Often-missed Liver Disorder Linked to Higher Heart Disease Risk - Vimarsana News

About 1 in 4 Adults has an Often-missed Liver Disorder Linked to Higher Heart Disease Risk

NAFLD can lead to permanent liver damage, and heart disease is the leading cause of death in people with fatty liver disease.

Esperion Announces Two NEXLETOL Data Presentations at ACC.22 - Vimarsana News

Esperion Announces Two NEXLETOL Data Presentations at ACC.22

New analyses of thousands of patients spanning Phase 2 and pooled Phase 3 data demonstrate that NEXLETOL safely and significantly lowers LDL-C compared to placebo in patients with renal impairment or hypertension

Esperion Announces Two NEXLETOL® (bempedoic acid) Data Presentations at the American College of Cardiology's 71st Annual Scientific Session & Expo - Press Release - Vimarsana News

Esperion Announces Two NEXLETOL® (bempedoic acid) Data Presentations at the American College of Cardiology's 71st Annual Scientific Session & Expo - Press Release

ANN ARBOR, Mich., April 03, 2022 (GLOBE NEWSWIRE) -- Esperion ESPR today presented two new analyses from its clinical development program of bempedoic